Needham & Company LLC Reaffirms Hold Rating for Docusign (NASDAQ:DOCU)

Key Points

• Needham & Company reaffirmed its “Hold” rating on Docusign, while analysts overall maintain an average “Hold” rating with an average price target of $60.60.
• Docusign’s latest quarterly results exceeded expectations, with earnings of $1.16 per share versus the $1.09 consensus and revenue of $875.75 million versus estimates of $867.22 million; revenue rose 9.4% year over year.
• Docusign shares opened at $65.97, with a market capitalization of approximately $12.6 billion. Insiders sold 90,602 shares worth about $4.3 million during the quarter, while institutional investors own 77.64% of the stock.

Docusign (NASDAQ:DOCU - Get Free Report)'s stock had its "hold" rating reiterated by Needham & Company LLC in a report issued on Friday, Marketbeat.com reports.

A number of other research firms have also recently weighed in on DOCU. UBS Group set a $60.00 price objective on Docusign in a research report on Friday, June 5th. Citizens Jmp reissued a "market outperform" rating and issued a $86.00 target price on shares of Docusign in a report on Tuesday, August 18th. Wells Fargo & Company cut their price target on Docusign from $60.00 to $55.00 and set an "equal weight" rating for the company in a research note on Friday, June 5th. Citigroup reaffirmed a "market outperform" rating on shares of Docusign in a report on Tuesday, August 18th. Finally, Wedbush lowered their price objective on shares of Docusign from $60.00 to $58.00 and set a "neutral" rating on the stock in a research report on Friday, June 5th. Four research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $60.60.

Docusign Stock Performance

DOCU opened at $65.97 on Friday. Docusign has a one year low of $40.16 and a one year high of $86.65. The company has a market cap of $12.60 billion, a P/E ratio of 42.84, a PEG ratio of 2.32 and a beta of 0.90. The business's 50-day simple moving average is $55.24 and its 200-day simple moving average is $49.74.

Docusign (NASDAQ:DOCU - Get Free Report) last posted its earnings results on Thursday, September 3rd. The company reported $1.16 EPS for the quarter, topping analysts' consensus estimates of $1.09 by $0.07. The business had revenue of $875.75 million for the quarter, compared to analysts' expectations of $867.22 million. Docusign had a return on equity of 17.48% and a net margin of 9.59%.The business's revenue was up 9.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.30 earnings per share. As a group, analysts predict that Docusign will post 2.03 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, insider James P. Shaughnessy sold 12,000 shares of the company's stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $45.54, for a total value of $546,480.00. Following the sale, the insider directly owned 52,815 shares in the company, valued at $2,405,195.10. This represents a 18.51% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CRO Paula Hansen sold 6,000 shares of the company's stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $45.54, for a total transaction of $273,240.00. Following the completion of the transaction, the executive owned 89,972 shares in the company, valued at approximately $4,097,324.88. This trade represents a 6.25% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 90,602 shares of company stock valued at $4,323,749. Company insiders own 0.59% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of DOCU. Modus Advisors LLC acquired a new stake in Docusign during the fourth quarter worth about $27,000. Cary Street Partners Investment Advisory LLC lifted its stake in shares of Docusign by 309.5% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 561 shares of the company's stock valued at $38,000 after purchasing an additional 424 shares in the last quarter. Basepoint Wealth LLC purchased a new stake in shares of Docusign during the 4th quarter worth about $39,000. WealthCollab LLC grew its holdings in shares of Docusign by 372.4% during the 1st quarter. WealthCollab LLC now owns 855 shares of the company's stock worth $41,000 after purchasing an additional 674 shares during the period. Finally, Virtus Advisers LLC acquired a new stake in Docusign during the 2nd quarter worth approximately $47,000. Institutional investors and hedge funds own 77.64% of the company's stock.

Trending Headlines about Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: DocuSign reported fiscal Q2 revenue of $875.7 million, up 9.4% year over year and ahead of the $867.2 million consensus estimate. Adjusted earnings of $1.16 per share also exceeded expectations of approximately $1.08-$1.09. DocuSign fiscal second-quarter results
• Positive Sentiment: The company raised its fiscal 2027 revenue, annual recurring revenue (ARR) and IAM-mix outlook. Management cited accelerating adoption of its AI-enabled IAM platform, which uses agreement data to support broader workflow and productivity applications. DocuSign raises forecast on AI momentum
• Positive Sentiment: DocuSign expects fiscal Q3 revenue of $886 million to $890 million, broadly around analyst expectations, while full-year revenue guidance is approximately $3.5 billion. The outlook suggests continued stability in the core e-signature business as newer IAM products gain traction.
• Positive Sentiment: BTIG Research raised its price target on DOCU from $60 to $75 and upgraded the shares to Buy, adding a favorable analyst signal following the earnings release. BTIG raises DocuSign price target
• Neutral Sentiment: Although the earnings and revenue beats were positive, fiscal Q3 revenue guidance was largely in line with consensus rather than materially above it. Investors will likely focus on whether IAM and AI adoption can accelerate growth beyond the current roughly 9% pace.
• Positive Sentiment: Separately, consulting firm BearingPoint integrated its GenAIQ tool with DocuSign IAM, potentially expanding use of the platform in procurement and contract-management workflows. BearingPoint integrates GenAIQ with DocuSign IAM

Docusign Company Profile

DocuSign, Inc NASDAQ: DOCU is a leading provider of electronic signature and digital transaction management solutions. The company's flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign's Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign's platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source